Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("GELMON, Karen A")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 29

  • Page / 2
Export

Selection :

  • and

Does multicentric/multifocal breast cancer differ from unifocal breast cancer? An analysis of survival and contralateral breast cancer incidenceYERUSHALMI, Rinat; KENNECKE, Hagen; WOODS, Ryan et al.Breast cancer research and treatment. 2009, Vol 117, Num 2, pp 365-370, issn 0167-6806, 6 p.Article

Trastuzumab -associated peripheral vascular toxicityPANSEGRAU, Gary K; GRANT, Dennis R; NORRIS, Brian et al.Journal of clinical oncology. 2007, Vol 25, Num 11, pp 1438-1440, issn 0732-183X, 3 p.Article

Columnar cell lesions, mammographic density and breast cancer riskTURASHVILI, Gulisa; MCKINNEY, Steven; MARTIN, Lisa et al.Breast cancer research and treatment. 2009, Vol 115, Num 3, pp 561-571, issn 0167-6806, 11 p.Article

Safety, Pharmacokinetics, and Efficacy of CPX-1 Liposome Injection in Patients with Advanced Solid TumorsBATIST, Gerald; GELMON, Karen A; CHI, Kim N et al.Clinical cancer research (Print). 2009, Vol 15, Num 2, pp 692-700, issn 1078-0432, 9 p.Article

A Case-Match Study Comparing Unilateral With Synchronous Bilateral Breast Cancer OutcomesNICHOL, Alan M; YERUSHALMI, Rinat; TYLDESLEY, Scott et al.Journal of clinical oncology. 2011, Vol 29, Num 36, pp 4763-4768, issn 0732-183X, 6 p.Article

Phase II Trial of Pertuzumab and Trastuzumab in Patients With Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer That Progressed During Prior Trastuzumab TherapyBASELGA, José; GELMON, Karen A; FUMOLEAU, Pierre et al.Journal of clinical oncology. 2010, Vol 28, Num 7, pp 1138-1144, issn 0732-183X, 7 p.Article

Effectiveness of a Letter Notification Program for Women With Early-Stage Breast Cancer Eligible for Extended Adjuvant LetrozoleMCARTHUR, Heather L; GELMON, Karen A; OLIVOTTO, Ivo A et al.Journal of clinical oncology. 2009, Vol 27, Num 9, pp 1388-1393, issn 0732-183X, 6 p.Article

Treatment of lymph-node-negative, oestrogen-receptor-positive breast cancer: Long-term findings from National Surgical Adjuvant Breast and Bowel Project randomised clinical trials. CommentaryFISHER, Bernard; JEONG, Jong-Hyeon; BRYANT, John et al.Lancet (British edition). 2004, Vol 364, Num 9437, pp 820-821, issn 0140-6736, 13 p.Article

Exemestane Versus Anastrozole in Postmenopausal Women With Early Breast Cancer: NCIC CTG MA.27—A Randomized Controlled Phase III TrialGOSS, Paul E; INGLE, James N; D'SOUZA, David P et al.Journal of clinical oncology. 2013, Vol 31, Num 11, pp 1398-1404, issn 0732-183X, 7 p.Article

Exemestane for Breast-Cancer Prevention in Postmenopausal WomenGOSS, Paul E; INGLE, James N; WINQUIST, Eric et al.The New England journal of medicine. 2011, Vol 364, Num 25, pp 2381-2391, issn 0028-4793, 11 p.Article

Facilitated Fast Track Referral Reduces Time from Abnormal Screening Mammogram to DiagnosisBORUGIAN, Marilyn J; GORDON, Paula B; KAN, Lisa et al.Canadian journal of public health. 2008, Vol 99, Num 4, pp 252-256, issn 0008-4263, 5 p.Article

Cancer Treatment-Induced Bone Loss in Breast and Prostate CancerSAAD, Fred; ADACHI, Jonathan D; BROWN, Jacques P et al.Journal of clinical oncology. 2008, Vol 26, Num 33, pp 5465-5476, issn 0732-183X, 12 p.Article

Phase I dose-finding study of a new taxane, RPR 109881A, administered as a one-hour intravenous infusion days 1 and 8 to patients with advanced solid tumorsGELMON, Karen A; LATREILLE, Jean; BESENVAL, Michele et al.Journal of clinical oncology. 2000, Vol 18, Num 24, pp 4098-4108, issn 0732-183XArticle

Feasibility of a Lifestyle Intervention on Body Weight and Serum Biomarkers in Breast Cancer Survivors with Overweight and ObesityCAMPBELL, Kristin L; VAN PATTEN, Cheri L; NEIL, Sarah E et al.Journal of the Academy of Nutrition and Dietetics (Print). 2012, Vol 112, Num 4, pp 559-567, issn 2212-2672, 9 p.Article

Evaluation of metformin in early breast cancer: a modification of the traditional paradigm for clinical testing of anti-cancer agentsGOODWIN, Pamela J; STAMBOLIC, Vuk; PRITCHARD, Kathleen I et al.Breast cancer research and treatment. 2011, Vol 126, Num 1, pp 215-220, issn 0167-6806, 6 p.Article

Stromal mast cells in invasive breast cancer are a marker of favourable prognosis : a study of 4,444 casesRAJPUT, Ashish B; TURBIN, Dmitry A; CHEANG, Maggie C. U et al.Breast cancer research and treatment. 2008, Vol 107, Num 2, pp 249-257, issn 0167-6806, 9 p.Article

Immunohistochemical detection using the new rabbit monoclonal antibody SP1 of estrogen receptor in breast cancer is superior to mouse monoclonal antibody 1D5 in predicting survivalCHEANG, Maggie C. U; TREABA, Diana O; NIELSEN, Torsten O et al.Journal of clinical oncology. 2006, Vol 24, Num 36, pp 5637-5644, issn 0732-183X, 8 p.Article

Population-based validation of the prognostic model ADJUVANT! for early breast cancerOLIVOTTO, Ivo A; BAJDIK, Chris D; RAVDIN, Peter M et al.Journal of clinical oncology. 2005, Vol 23, Num 12, pp 2716-2725, issn 0732-183X, 10 p.Article

Overexpression of the anti-adhesin podocalyxin is an independent predictor of breast cancer progressionSOMASIRI, Aruna; NIELSEN, Julie S; MCNAGNY, Kelly M et al.Cancer research (Baltimore). 2004, Vol 64, Num 15, pp 5068-5073, issn 0008-5472, 6 p.Article

Randomized Phase II Study Comparing Two Schedules of Everolimus in Patients With Recurrent/Metastatic Breast Cancer: NCIC Clinical Trials Group IND.163ELLARD, Susan L; CLEMONS, Mark; SAUERBREI, Eric et al.Journal of clinical oncology. 2009, Vol 27, Num 27, pp 4536-4541, issn 0732-183X, 6 p.Article

Cardiac Safety Analysis of Doxorubicin and Cyclophosphamide Followed by Paclitaxel With or Without Trastuzumab in the North Central Cancer Treatment Group N9831 Adjuvant Breast Cancer TrialPEREZ, Edith A; SUMAN, Vera J; WINER, Eric P et al.Journal of clinical oncology. 2008, Vol 26, Num 8, pp 1231-1238, issn 0732-183X, 8 p.Article

Identification of Cancer Care and Protocol Characteristics Associated With Recruitment in Breast Cancer Clinical TrialsLEMIEUX, Julie; GOODWIN, Pamela J; PRITCHARD, Kathleen I et al.Journal of clinical oncology. 2008, Vol 26, Num 27, pp 4458-4465, issn 0732-183X, 8 p.Article

The impact of new chemotherapeutic and hormone agents on survival in a population-based cohort of women with metastatic breast cancerCHIA, Stephen K; SPEERS, Caroline H; D'YACHKOVA, Yulia et al.Cancer. 2007, Vol 110, Num 5, pp 973-979, issn 0008-543X, 7 p.Article

Preferential dependence of breast cancer cells versus normal cells on integrin-linked kinase for protein kinase B/Akt activation and cell survivalTROUSSARD, Armelle A; MCDONALD, Paul C; DEDHAR, Shoukat et al.Cancer research (Baltimore). 2006, Vol 66, Num 1, pp 393-403, issn 0008-5472, 11 p.Article

Effect of soy phytoestrogens on hot flashes in postmenopausal women with breast cancer: A randomized, controlled clinical trialVAN PATTEN, Cheri L; OLIVOTTO, Ivo A; CHAMBERS, G. Keith et al.Journal of clinical oncology. 2002, Vol 20, Num 6, pp 1449-1455, issn 0732-183XArticle

  • Page / 2